Novavax - Model RSV F - Combination Seasonal Influenza Vaccine
From Respiratory Syncytial Virus (RSV)
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations against both diseases. Although testing is at an early stage, we believe that a combination vaccine against both seasonal influenza and RSV may be achievable.
Customer reviews
No reviews were found for Novavax - Model RSV F - Combination Seasonal Influenza Vaccine. Be the first to review!